New MS drug aims to match blockbuster treatment
Disease control
Recruiting now
This study is testing if a new drug called CYB704 works the same way as the established MS treatment Ocrevus. Researchers will compare how the two drugs are processed by the body, their effectiveness, and their side effects in 175 adults with relapsing multiple sclerosis. The goa…
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC